ESCP Safe Anastomosis proGramme in coLorectal surgEry

Overview

EAGLE is an international service improvement study to investigate the value of an educational tool delivered to surgeons and their teams to reduce the risk of anastomotic leak (leak of a join in the bowel) after right hemicolectomy or ileocaecal resection. This complication causes significant risk to life and therefore risks of leak should be minimised. The educational team of the European Society of Coloproctology has developed an online training package to deliver to 350 hospitals in 30 countries.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Sequential Assignment
    • Primary Purpose: Prevention
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: December 31, 2020

Detailed Description

EAGLE is an international quality improvement programme to share best practice and harmonise ileo-colic anastomosis procedures through an education programme for surgeons and theatre teams. The programme has 3 main strategies: (i) enhanced pre-operative risk stratification (making sure it is safe to join the bowel together for each patient); (ii) harmonisation of surgical technique (making the join as good as it can be and checking it carefully after it is created), and (iii) implementation of an intra-operative anastomosis 'checklist' (focusing the attention of the whole theatre team at this critical stage of the operation). The investigators will use a novel scientific approach to assess the patient benefit that enables not only the quality improvement itself to be delivered to all participating hospitals but also enables collection and analysis of data to measure the effect of these measures. The best way of doing this is to embed the proposed quality improvement into a staggered implementation programme, allowing the effect to be assessed between the centres. The specific methodology proposed introduces the intervention in a step-wise fashion to all hospitals. By the end, all sites will have implemented the programme. Overall, the investigators hope to reduce the leak rate by 30% from 8.1% to 5.6% in about 4,500 patients.

Interventions

  • Behavioral: The EAGLE Safe Anastomosis Quality Improvement Intervention
    • The intervention is the same in each arm; the EAGLE Safe Anastomosis Quality Improvement Intervention is an educational programme for behavioural change composed of three parts: Introduction of a routine patient risk stratification for anastomotic leak Implementation of the ESCP Safe Anastomosis Checklist Adoption of a harmonised technique for stapled and handsewn anastomosis based on best evidence.

Arms, Groups and Cohorts

  • Experimental: After intervention (sequence 1)
    • ‘After intervention’ group receives the training immediately and data are only collected after the intervention.
  • Experimental: Before and after intervention (sequence 2)
    • For the ‘Before and after intervention’ group, data are collected both before and after the training.
  • No Intervention: Before intervention (sequence 3)
    • The ‘before intervention’ group collects data only before the training. *This arm will receive the educational intervention after data collection is completed.

Clinical Trial Outcome Measures

Primary Measures

  • Number of patients diagnosed clinically or radiologically with anastomotic leak within 30 days of surgery
    • Time Frame: up to 30 days from operation
    • Anastomotic leak is defined as anastomotic leak identified radiologically or clinically, or intra-peritoneal (abdominal or pelvic) fluid collection identified radiologically, as per the Centre for Disease Control Criteria for Organ Space infection. This will be described as a rate divided by the total number of patients who had a primary anastomosis (rather than total number of patients undergoing right hemicolectomy or ileocaecal resection).

Secondary Measures

  • The rate of re-operation for anastomotic leak
    • Time Frame: up to 30 days
    • The number of patients re-operated, of those diagnosed with anastomotic leak following right hemicolectomy or ileocaecal resection
  • The rate of adverse outcomes following right hemicolectomy or ileocaecal resection
    • Time Frame: up to 30 days
    • For all patients included in the study (i.e. who underwent right hemicolectomy or ileocaecal resection whether or not with primary anastomosis); Number of patients undergoing re-operation for any cause within 30 days Number of patients with unplanned admission to critical care within 30 days Number of patients re-admitted to hospital within 30 days Mortality rate within 30 days
  • The rate of stoma formation
    • Time Frame: At index operation
    • For all patients included in the study (i.e. who underwent right hemicolectomy or ileocaecal resection whether or not with primary anastomosis); Rate of formation of ileostomy without primary anastomosis Rate of defunctioning ileostomy with primary anastomosis
  • Length of hospital stay following right hemicolectomy or ileocaecal resection
    • Time Frame: up to 30 days
    • Measured in post-operative days

Participating in This Clinical Trial

Inclusion Criteria

  • All adult patients (age 18 years and above) undergoing right colectomy with or without primary anastomosis. Right colectomy is defined as ileocaecal resection or right hemicolectomy (any colonic transection with the distal resection margin proximal to the splenic flexure). – All patients undergoing right colectomy are eligible, including those who do not have an anastomosis and are defunctioned by a proximal stoma. – Procedures for any pathology, via any operative approach (open, laparoscopic, robotic or converted) are eligible. – Elective (surgery on a planned admission), expedited, and emergency (surgery on an unplanned admission) procedures are eligible. Exclusion Criteria:
  • Patients undergoing more than one gastrointestinal anastomosis during the same operation. – In Crohn's disease, additional upstream stricturoplasty or resection/anastomosis to treat disease or strictures at the same operation. – Simultaneous right colectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) and/or cytoreductive surgery. – Each individual patient should only be included in EAGLE once. Following the index procedure that is included in EAGLE, patients undergoing additional procedures within the study window should not be included for a second time.
  • Gender Eligibility: All

    Minimum Age: 18 Years

    Maximum Age: N/A

    Are Healthy Volunteers Accepted: No

    Investigator Details

    • Lead Sponsor
      • University of Birmingham
    • Collaborator
      • Ethicon, Inc.
    • Provider of Information About this Clinical Study
      • Sponsor
    • Overall Official(s)
      • Dion Morton, Principal Investigator, University of Birmingham
    • Overall Contact(s)
      • James Keatley, +44 (0)121 371 8026, J.Keatley@bham.ac.uk

    Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

    At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.